University of North Carolina Hospitals Hematology and Medical Oncology

Topics

• Hemophilia Treatment and Research 266
• Cancer survivorship and care 218
• Venous Thromboembolism Diagnosis and Management 186
• Breast Cancer Treatment Studies 164
• Cancer Immunotherapy and Biomarkers 164
• Bladder and Urothelial Cancer Treatments 162
• Hemoglobinopathies and Related Disorders 158
• Virus-based gene therapy research 138
• CAR-T cell therapy research 118
• Acute Myeloid Leukemia Research 114
• Lymphoma Diagnosis and Treatment 107
• Hematopoietic Stem Cell Transplantation 104

Most cited

1. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2024 · 832 citations · Lisa Carey

2. Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.

   The New England journal of medicine · 2025 · 482 citations · Charles Cowey

3. Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.

   Lancet (London, England) · 2024 · 686 citations · Charles Cowey

4. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.

   European urology · 2024 · 496 citations · Matthew Milowsky

5. 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

   Circulation · 2026 · 118 citations · Karlyn Martin

6. Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

   The New England journal of medicine · 2021 · 1,378 citations · Lisa Carey